Elanco Animal Health Inc (ELAN)
13.57
+0.16
(+1.19%)
USD |
NYSE |
Apr 18, 16:00
13.58
+0.01
(+0.07%)
After-Hours: 20:00
Elanco Animal Health Cash from Financing (TTM): -83.00M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -83.00M |
September 30, 2023 | -28.00M |
June 30, 2023 | -40.00M |
March 31, 2023 | -175.00M |
December 31, 2022 | -549.00M |
September 30, 2022 | -421.00M |
June 30, 2022 | -21.00M |
March 31, 2022 | 8.00M |
December 31, 2021 | 210.00M |
September 30, 2021 | 148.00M |
June 30, 2021 | 3.985B |
Date | Value |
---|---|
March 31, 2021 | 4.059B |
December 31, 2020 | 4.954B |
September 30, 2020 | 4.966B |
June 30, 2020 | 848.80M |
March 31, 2020 | 931.50M |
December 31, 2019 | -305.00M |
September 30, 2019 | -661.00M |
June 30, 2019 | -161.30M |
March 31, 2019 | -298.20M |
December 31, 2018 | -35.20M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-661.00M
Minimum
Sep 2019
4.966B
Maximum
Sep 2020
929.77M
Average
-21.00M
Median
Jun 2022
Cash from Financing (TTM) Benchmarks
Merck & Co Inc | -4.81B |
Catalent Inc | 8.00M |
NanoString Technologies Inc | 1.619M |
Cytokinetics Inc | 221.32M |
Geron Corp | 362.02M |